跳至主要内容
临床试验/JPRN-UMIN000012716
JPRN-UMIN000012716已完成2 期

Clinical efficacy and safety of the ealry intervention with Tolvaptan(V2 receptorinhibiter)in hospitalized patients with acute exacerbation of chronic heart failur:A randomized open-labeled parallel controlled study - Clinical efficacy and safety of the ealry intervention with Tolvaptan(V2 receptorinhibiter)in hospitalized patients with acute exacerbation of chronic heart failur:A randomized open-labeled parallel controlled study

JI-TOKUSHUKAI MEDICAL CENTER Cardiovascular Medicine0 个研究点目标入组 100 人开始时间: 2013年12月27日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1 Patients with a history of hypersensitivity for an ingredient of tolvaptan or analogues such as Mozavaptan. 2 Patients with lowering consciousness. 3 Patients who need treatment with respirator. 4 Patients who receive artificial dialysis. 5 Patients with anuria. 6 Patients with severe liver disfunction. 7 Patients who cannot feel thirst or are difficult to intake the fluid. 8 Patients with hypernatremia. 9 Female patients who are pregnant, possibly pregnant, or lactating, or who plan to become pregnant. 10 Patients otherwise judged by the investigator or sub-investigator to be inappropriate for inclusion in the study.

研究者

发起方
JI-TOKUSHUKAI MEDICAL CENTER Cardiovascular Medicine

相似试验